Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates

BACKGROUND: Nevirapine (NVP) is a key component of antiretroviral prophylaxis and treatment for neonates. We evaluated current WHO weight-band NVP prophylactic dosing recommendations and investigated optimal therapeutic NVP dosing for neonates. METHODS: The PHPT-5 study in Thailand assessed the effi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Acquir Immune Defic Syndr
Päätekijät: Cressey, Tim R., Punyawudho, Baralee, Le Coeur, Sophie, Jourdain, Gonzague, Saenjum, Chalermpong, Capparelli, Edmund, Jittayanun, Kanokwan, Phanomcheong, Siriluk, Luvira, Anita, Borkird, Thitiporn, Puangsombat, Achara, Aarons, Leon, Sukrakanchana, Pra-ornsuda, Urien, Saik, Lallemant, Marc
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5508655/
https://ncbi.nlm.nih.gov/pubmed/28489732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001447
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia